30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mark Goldsmith

Track

Insider profile

Currently holds positions in Revolution Medicines Inc and Constellation Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Founding President, Chief Executive Officer, Board Director Revolution Medicines Inc None -
Independent Chairman of the Board Constellation Pharmaceuticals Inc July 1, 2009 -
Chairman of the Board Nurix Therapeutics Inc Sept. 18, 2014 - Jan. 1, 2016
Chairman of the Board, Chief Executive Officer Nurix Therapeutics Inc None -
Chief Executive Officer, Board Member Global Blood Therapeutics Inc None -
Mark Goldsmith's trades of Revolution Medicines Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-15
PrS Proposed sale
37,581
481.38
US$3,090,450 		37,581 481.38 US$3,090,450
2026-04-17 2026-04-15
PlS Planned sale
27,039 -21.9%
185.10
US$3,222,354 		27,039 -21.9% 185.10 US$3,222,354
2026-04-15 2026-04-15
PrS Proposed sale
70,134
419.03
US$2,965,846 		70,134 419.03 US$2,965,846
2026-03-19 2026-03-17
PlS Planned sale
12,871 -4.4%
99.48
US$1,280,412 		12,871 -4.4% 99.48 US$1,280,412
2026-03-13 2026-03-16
PrS Proposed sale
13,261
99.59
US$1,320,663 		13,261 99.59 US$1,320,663
2026-03-03 2026-03-02
S Sale
200 -0.3%
102.08
US$20,416 		200 -0.3% 102.08 US$20,416
2026-03-03 2026-03-02
S Sale
2,100 -3.1%
101.63
US$213,432 		2,100 -3.1% 101.63 US$213,432
2026-03-03 2026-03-02
S Sale
600 -0.9%
100.19
US$60,116 		600 -0.9% 100.19 US$60,116
2026-03-03 2026-03-02
S Sale
100 -0.1%
98.29
US$9,829 		100 -0.1% 98.29 US$9,829
2026-03-03 2026-03-02
S Sale
800 -1.2%
102.00
US$81,599 		800 -1.2% 102.00 US$81,599
2026-03-03 2026-03-02
S Sale
1,700 -2.5%
101.47
US$172,506 		1,700 -2.5% 101.47 US$172,506
2026-03-03 2026-03-02
S Sale
400 -0.6%
100.12
US$40,049 		400 -0.6% 100.12 US$40,049
2026-03-03 2026-03-02
S Sale
100 -0.1%
98.31
US$9,831 		100 -0.1% 98.31 US$9,831
2026-03-03 2026-03-02
PlS Planned sale
851 -0.3%
102.20
US$86,972 		851 -0.3% 102.20 US$86,972
2026-03-03 2026-03-02
PlS Planned sale
21,329 -6.8%
101.60
US$2,167,075 		21,329 -6.8% 101.60 US$2,167,075
2026-03-03 2026-03-02
PlS Planned sale
3,620 -1.1%
100.73
US$364,659 		3,620 -1.1% 100.73 US$364,659
2026-03-03 2026-03-02
PlS Planned sale
3,500 -1.1%
99.76
US$349,150 		3,500 -1.1% 99.76 US$349,150
2026-03-03 2026-03-02
PlS Planned sale
700 -0.2%
98.17
US$68,720 		700 -0.2% 98.17 US$68,720
2026-03-02 2026-03-02
PrS Proposed sale
3,000
102.02
US$306,060 		3,000 102.02 US$306,060
2026-03-02 2026-03-02
PrS Proposed sale
3,000
102.02
US$306,060 		3,000 102.02 US$306,060
2026-03-02 2026-03-02
PrS Proposed sale
30,000
102.02
US$3,060,600 		30,000 102.02 US$3,060,600
2025-12-18 2025-12-16
PlS Planned sale
15,394 -6.2%
76.82
US$1,182,526 		15,394 -6.2% 76.82 US$1,182,526
2025-12-12 2025-12-15
PrS Proposed sale
14,964
77.81
US$1,164,349 		14,964 77.81 US$1,164,349
2025-11-26 2025-11-25
S Sale
3,000 -4.3%
75.00
US$225,000 		3,000 -4.3% 75.00 US$225,000
2025-11-26 2025-11-25
S Sale
3,000 -4.3%
75.00
US$225,000 		3,000 -4.3% 75.00 US$225,000
2025-11-26 2025-11-25
PlS Planned sale
60,000 -19.5%
75.08
US$4,504,962 		60,000 -19.5% 75.08 US$4,504,962
2025-11-25 2025-11-25
PrS Proposed sale
3,000
73.66
US$220,980 		3,000 73.66 US$220,980
2025-11-25 2025-11-25
PrS Proposed sale
3,000
73.66
US$220,980 		3,000 73.66 US$220,980
2025-11-25 2025-11-25
PrS Proposed sale
60,000
73.66
US$4,419,600 		60,000 73.66 US$4,419,600
2025-11-20 2025-11-18
PlS Planned sale
20,000 -7.5%
70.38
US$1,407,586 		20,000 -7.5% 70.38 US$1,407,586
2025-11-18 2025-11-18
PrS Proposed sale
20,000
69.14
US$1,382,800 		20,000 69.14 US$1,382,800
2025-11-14 2025-11-12
PlS Planned sale
20,000 -7.5%
65.07
US$1,301,410 		20,000 -7.5% 65.07 US$1,301,410
2025-11-12 2025-11-12
PrS Proposed sale
20,000
64.08
US$1,281,600 		20,000 64.08 US$1,281,600
2025-11-12 2025-11-07
PlS Planned sale
30,000 -7.9%
60.31
US$1,809,306 		30,000 -7.9% 60.31 US$1,809,306
2025-11-07 2025-11-07
PrS Proposed sale
30,000
61.38
US$1,841,400 		30,000 61.38 US$1,841,400
2025-10-20 2025-10-17
PlS Planned sale
10,000 -2.2%
55.00
US$550,000 		10,000 -2.2% 55.00 US$550,000
2025-10-17 2025-10-17
PrS Proposed sale
10,000
49.68
US$496,800 		10,000 49.68 US$496,800
2025-10-20 2025-10-16
PlS Planned sale
10,000 -2.2%
50.47
US$504,701 		10,000 -2.2% 50.47 US$504,701
2025-10-16 2025-10-16
PrS Proposed sale
10,000
49.56
US$495,600 		10,000 49.56 US$495,600
2025-09-18 2025-09-16
PlS Planned sale
13,411 -2.9%
45.82
US$614,558 		13,411 -2.9% 45.82 US$614,558
2025-09-15 2025-09-15
PrS Proposed sale
13,236
46.55
US$616,136 		13,236 46.55 US$616,136
2025-06-18 2025-06-16
PlS Planned sale
13,496 -3.1%
39.83
US$537,546 		13,496 -3.1% 39.83 US$537,546
2025-06-13 2025-06-16
PrS Proposed sale
13,235
40.79
US$539,856 		13,235 40.79 US$539,856
2025-03-19 2025-03-17
PlS Planned sale
11,738 -2.6%
39.04
US$458,255 		11,738 -2.6% 39.04 US$458,255
2025-03-14 2025-03-17
PrS Proposed sale
11,890
38.89
US$462,402 		11,890 38.89 US$462,402